- Home
- ADTN vs AVXL Comparison
ADTN vs AVXL Comparison
Compare ADTN & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTN
- AVXL
- Stock Information
- Founded
- ADTN 1985
- AVXL 2004
- Country
- ADTN United States
- AVXL United States
- Employees
- ADTN N/A
- AVXL 2
- Industry
- ADTN Telecommunications Equipment
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ADTN Telecommunications
- AVXL Health Care
- Exchange
- ADTN Nasdaq
- AVXL Nasdaq
- Market Cap
- ADTN 708.5M
- AVXL 635.6M
- IPO Year
- ADTN 1994
- AVXL N/A
- Fundamental
- Price
- ADTN $7.97
- AVXL $7.19
- Analyst Decision
- ADTN Strong Buy
- AVXL Strong Buy
- Analyst Count
- ADTN 5
- AVXL 3
- Target Price
- ADTN $12.80
- AVXL $44.00
- AVG Volume (30 Days)
- ADTN 2.0M
- AVXL 1.1M
- Earning Date
- ADTN 11-03-2025
- AVXL 12-22-2025
- Dividend Yield
- ADTN N/A
- AVXL N/A
- EPS Growth
- ADTN N/A
- AVXL N/A
- EPS
- ADTN N/A
- AVXL N/A
- Revenue
- ADTN $1,035,099,000.00
- AVXL N/A
- Revenue This Year
- ADTN $17.80
- AVXL N/A
- Revenue Next Year
- ADTN $8.37
- AVXL N/A
- P/E Ratio
- ADTN N/A
- AVXL N/A
- Revenue Growth
- ADTN 14.33
- AVXL N/A
- 52 Week Low
- ADTN $6.19
- AVXL $7.11
- 52 Week High
- ADTN $12.44
- AVXL $14.44
- Technical
- Relative Strength Index (RSI)
- ADTN 36.12
- AVXL 28.36
- Support Level
- ADTN $7.88
- AVXL $7.88
- Resistance Level
- ADTN $10.75
- AVXL $7.59
- Average True Range (ATR)
- ADTN 0.49
- AVXL 0.41
- MACD
- ADTN -0.23
- AVXL -0.13
- Stochastic Oscillator
- ADTN 8.06
- AVXL 7.11
About ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.